Open Access journal

OncoDaily

News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary

Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me

March, 2025

Open Access journal

Nov 22, 2024, 12:36 | Insight

Regulating the Hippo pathway with the New class of TEAD small molecule inhibitors

Anirban Maitra shared a post on X: "And right on cue! Preprint from Genentech on a…

Jul 4, 2024, 08:53 | Blog

Jan Cools: 2023 journal impact factor of HemaSphere Journal is 12.1

Jan Cools, Editor in Chief of HemaSphere, journal of EHA at European Hematology Association (EHA), made…

May 21, 2024, 12:41 | Blog

Danny Burke: Our open-access journal has been accepted to be indexed in the Asian Science Citation Index

Danny Burke, CEO of ecancer, shared on LinkedIn: "Our open-access journal has been accepted to be…

Apr 18, 2024, 14:25 | Blog

Jorge Cortes: I am honored to serve as editor-in-chief of Blood Global Hematology from ASH

Jorge Cortes, Director of the Georgia Cancer Center, shared on X/Twitter: "I am honored to…

Mar 8, 2024, 19:21 | Societies

Our Editor Spotlight this week is Chiara Cremolini - ESMO Open

ESMO Open Journal announced on their X/Twitter page: "Our Editor Spotlight this week is Chiara…

All: 5 Posts: 1 - 100

'

Karen Knudsen has been appointed as the CEO of the Parker Institute for Cancer Immunotherapy

'

Highlights from ELCC 2025

'

FDA Approved Pluvicto (177Lu-PSMA-617) for Metastatic Castration-Resistant Prostate Cancer

'

Meet the New AACR Board of Directores for 2025-2028 Term

'

Do Artificial Sweeteners Cause Cancer? Myths and Facts

Special Coverage

Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
ESMO 2024 Congress
September 13-17, 2024
ASCO Annual Meeting
May 30 - June 4, 2024
Yvonne Award 2024
May 31, 2024
OncoThon 2024, Online
Feb. 15, 2024
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023